Variant position: 453 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 933 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human VYQEARKVVGALHQIITLRD YIPRILGPEAFQQYVGPYEGY
Mouse AYQEARKVVGALHQIITMRD YIPKILGPDAFRQYVGPYEGY
Rat AYQEARKVVGALHQIITMRD YIPKILGPDAFRQYVGPYEGY
Pig VYQEARKVVGALHQIVTLRD YVPKILGAEAFGQHVGPYQGY
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
19 – 933 Thyroid peroxidase
19 – 846 Extracellular
Identification of five novel inactivating mutations in the human thyroid peroxidase gene by denaturing gradient gel electrophoresis.
Bikker H.; Vulsma T.; Baas F.; de Vijlder J.J.M.;
Hum. Mutat. 6:9-16(1995)
Cited for: VARIANTS TDH2A ASP-453; SER-590 AND LYS-799; VARIANTS SER-257; SER-373; THR-398 AND PRO-725;
Two decades of screening for congenital hypothyroidism in The Netherlands: TPO gene mutations in total iodide organification defects (an update).
Bakker B.; Bikker H.; Vulsma T.; de Randamie J.S.E.; Wiedijk B.M.; De Vijlder J.J.M.;
J. Clin. Endocrinol. Metab. 85:3708-3712(2000)
Cited for: VARIANTS TDH2A THR-326; PHE-447; ASP-453; CYS-527; TRP-693 AND LYS-799;
Goitrous congenital hypothyroidism and hearing impairment associated with mutations in the TPO and SLC26A4/PDS genes.
Pfarr N.; Borck G.; Turk A.; Napiontek U.; Keilmann A.; Mueller-Forell W.; Kopp P.; Pohlenz J.;
J. Clin. Endocrinol. Metab. 91:2678-2681(2006)
Cited for: VARIANT TDH2A ASP-453;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.